Multimodal Brain Monitoring as a Prognostic Tool for Intracerebral Hemorrhage
NCT ID: NCT05771662
Last Updated: 2023-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
25 participants
OBSERVATIONAL
2021-04-01
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Multimodal Neuromonitoring For Spontaneous Intracerebral Hemorrhage (ICH)
NCT05501613
Prospective Cohort of Patients With Intracerebral Hemorrhage
NCT06670456
Prospective Cohort Study of Intracerebral Hemorrhage
NCT04707105
Retrospective Cohort Study of Intracerebral Hemorrhage
NCT04803292
Interventional Study for Detection of Prognosis of Blood Based Biomarkers in Intracerebral Hemorrhage
NCT06745037
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ICU admission in the first 24hours
* Need for intraparenchymal Neuromonitoring
* Over 18 years old
Exclusion Criteria
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade do Porto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro Hospitalar São João
Porto, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ICH-NEUROICU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.